[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Page S6359]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3445. Mr. TILLIS submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 14, setting forth the 
congressional budget for the United States Government for fiscal year 
2022 and setting forth the appropriate budgetary levels for fiscal 
years 2023 through 2031; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO CONTINUED 
                   ACCESS TO THE WORLD'S BEST MEDICAL CURES AND 
                   TREATMENTS.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     ensuring that the United States continues to produce the best 
     and most innovative medical cures and treatments, which may 
     include prohibiting or limiting policies that would reduce 
     the number of medical cures, treatments, or vaccines 
     available to patients or that would increase list prices on 
     prescription drugs, resulting in higher costs for uninsured 
     Americans, by the amounts provided in such legislation for 
     those purposes, provided that such legislation would not 
     increase the deficit over either the period of the total of 
     fiscal years 2022 through 2026 or the period of the total of 
     fiscal years 2022 through 2031.
                                 ______